Cyclo Therapeutics Inc (CYTH)

Cyclo Therapeutics Inc Azioni (CYTH) Dati Finanziari

Conto economico

Trimestrale

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	34.99% 0.2025	0.3114	0.4955	0.1171	0.1524
Cost Of Revenue	0.0118	-	-	-	-
Gross Profit	0.1906	-	-	-	-
Operating Expenses	9.50% 5.3117	5.8696	5.2629	4.7501	5.1595
Benefits Costs and Expenses	23.65% 4.5455	5.9538	5.2668	4.7536	5.1595
Costs And Expenses	9.50% 5.3117	5.8696	5.2629	4.7501	5.1595
Operating Income/Loss	9.24% -5.1211	-5.6425	-4.7675	-4.6329	-5.0071
Nonoperating Income/Loss	682.36K% 0.778	0.000114	-0.00389	-0.00351	0.000047
Income/Loss From Continuing Operations Before Tax	23.03% -4.3431	-5.6424	-4.7714	-4.6365	-5.0071
Income Tax Expense/Benefit	-	-	-	-	-
Income/Loss From Continuing Operations After Tax	23.03% -4.3431	-5.6424	-4.7714	-4.6365	-5.0071
Net Income/Loss	23.03% -4.343	-5.6423	-4.771	-4.6365	-5.0071
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	1,377% 28.59	1.9348	16.19	14.04	11.00
Basic Earnings Per Share	34.78% -0.15	-0.23	-0.29	-0.33	-0.46
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-